Constructing germline research cohorts from the discarded reads of clinical tumor sequences
Abstract Background Hundreds of thousands of cancer patients have had targeted (panel) tumor sequencing to identify clinically meaningful mutations. In addition to improving patient outcomes, this activity has led to significant discoveries in basic and translational domains. However, the targeted n...
Guardado en:
Autores principales: | Alexander Gusev, Stefan Groha, Kodi Taraszka, Yevgeniy R. Semenov, Noah Zaitlen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dfd1ed628f8e4314b50a12954fd90ff0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identifying causal variants by fine mapping across multiple studies.
por: Nathan LaPierre, et al.
Publicado: (2021) -
Longitudinal and multi-tissue molecular diagnostics track somatic BRCA2 reversion mutations that correct the open reading frame of germline alteration upon clinical relapse
por: Shelly Sorrells, et al.
Publicado: (2021) -
Germline genome modification through novel political, ethical, and social lenses.
por: Vicki Xafis, et al.
Publicado: (2021) -
Germline genome editing: Moratorium, hard law, or an informed adaptive consensus?
por: Terry Kaan, et al.
Publicado: (2021) -
dRTEL1 is essential for the maintenance of Drosophila male germline stem cells.
por: Ying Yang, et al.
Publicado: (2021)